Join Free

Research and publish the best content.

Immunology and Biotherapies

38.0K views | +2 today

Tags

# acute B-cell lymphoblastic leukaemia 1

# Adenylate Cyclase vector platform CyaA 1

# Antibody Nanoparticle Conjugates 1

# CAR 1

# complement-dependent cytotoxicity 1

# dual variable domain immunoglobulin 1

# EBV-Lymphoproliferative Disease 1

# FcγRIIB (CD32B) Antibodies 1

# HNSTD, highest non-severely toxic dose 1

# HPMA copolymers 1

# IL-1α 1

# limbal stem cell deficiency LSCD 1

# liquid chromatography/mass spectrometr 1

# Mode of Action 1

# mogamulizumab (Poteligeo®) 1

# MUC1 targeting immunotherapy 1

# neuroblastoma 1

# Site-specific, novel Antibody Platform 1

# T cells 1

# TCR 1

# tumor-infiltrating lymphocytes (TILs) 1

# tumor-specific antigens 3

##top selling prescription drug 1

#4-IBB 1

#AACR 3

#AACR 2015 3

#AbbVie 2

#Abciximab 1

#abs-dependent cellular phagocytosis 1

#Abzena 1

#Actemra 2

#activated T cells 5

#Active immunotherapy 3

#acute lymphoblastic leukemia 1

#acute lymphoblastic leukemia ALL 1

#Adalimumab 4

#Adaptimmune 1

#Adaptive immunity 1

#adaptive lymphocytes 1

#ADC 4

#Adcetris 1

#adjuvant CpG 1

#adoptive cell therapy (ACT) 2

#adoptive cellular cancer immunotherapy 2

#Adoptive immunotherapy 6

#Adoptive T cell therapy 5

#ADRs 2

#Aducanumab 1

#adult T cell leukaemia/lymphoma 1

#adult T-cell leukemia/lymphoma (ATL) 1

#Advanced therapy 2

#Affimed Therapeutics 1

#Age-related macular degeneration 1

#AIDS 1

#alemtuzumab 1

#Alirocumab 2

#ALL 1

#allergy 1

#Allogeneic drugs 1

#Allogeneic tumor vaccine 1

#Alnylam 1

#Alzheimer's Disease 1

#AMD 1

#Amgen 2

#AML 1

#amyloid beta 1

#angiogenesis 1

#ankylosing spondylitis (AS) 1

#anti cancer peptides 1

#anti-cytokine therapy 1

#anti-KIR agents 1

#antibody aggregation 1

#Antibody coupled receptors 1

#antibody development 2

#antibody drug conjugate 3

#antibody drug conjugates 16

#Antibody engineering 5

#antibody fragment 4

#Antibody Glycosylation 2

#antibody therapy 3

#antibody tumor targeting 1

#Antibody-dep- cell-mediated cytotoxicit 1

#antibody-dependent cellular cytotoxicit 1

#Antibody–drug ratio (ADR) 1

#anticancer mabs 1

#antidrug antibodies 1

#Antifrolumab 1

#antigen-binding fragment 1

#Apellis Pharma 1

#Apoptosis 1

#arGEN-X 1

#ASCO 1

#ASCO 2014 1

#ASCO 2015 2

#ASCO GU 1

#Astra Zeneca 1

#atherosclerosis 1

#autoimmune diseases 2

#Avastin 3

#B cell NHL 1

#B7-H3 1

#bavituximab 1

#Bertilimumab 1

#best selling prescription drug 1

#beta-1-adrenergic receptor (β1AR) 1

#bevacizumab 3

#Bexsero 1

#BI 655066 mab 1

#Bi specific antibodies 3

#Bi specific antibody 1

#Bi specific mab 1

#Bi-specific monoclonal antibodies 2

#billion dollar mabs 1

#Biogen Idec 1

#biogenerics 4

#biologics 1

#biomarkers 1

#biopharmaceuticals 1

#biosimilar 5

#biosimilar market 1

#Biotech industry 1

#Biotest AG 1

#bispecific antibodies 2

#bispecific T-cell engager (BiTE) mabs 2

#Bispecific T-cell engagers (BiTEs) 1

#BiTE® 1

#Blinatumomab 2

#blockbuster mabs 2

#Blood-Brain Barrier Technology 1

#BMJ 1

#BMS 2

#Boehringer Ingelheim 1

#Bone morphogenic proteins 1

#braf inhibitor 1

#braf inhibitors 1

#BRAf inhibitors resistance 1

#BRAF+MEK therapy 1

#breakthrough drug 1

#Breakthrough Therapy Designation 2

#breakthrough therapy drugs 1

#breast cancer 1

#cancer 10

#cancer drugs 2

#cancer immunotherapy 11

#cancer vaccines 5

#CAR 5

#CAR T cell immunotherapy 12

#CAR T cell therapy 5

#CAR-TCR 5

#carbohydrate recognition 1

#Castleman disease 1

#castrate resistant prostate cancer 1

#CCR4 mab 1

#CD154 1

#CD20 2

#CD20 mab 1

#CD25 1

#CD32B 1

#CD4 1

#CD4+ helper T cells 2

#CD40 1

#CD40LGVAX 1

#CD47 mab 1

#CD8 T cells 2

#Cell 1

#cell death 2

#cell free protein synthesis 1

#Celltrion Healthcare 1

#Cellular Biomedicine 1

#Certolizumab 2

#cetuximab 2

#CH3/CH2 domain 1

#Characterization 1

#checkpoint blockade 2

#checkpoint inhibitor 10

#checkpoint inhibitors 18

#chemokine ligands 2

#Chiesi 1

#Chimeric Antigen Receptor 4

#Chimeric antigen receptors (CARs) 8

#CHMP 2

#cholesterol 1

#chronic lymphocytic leukemia 1

#clinical review 1

#CLL 2

#CMet inhibitors 1

#cMet signaling pathway 1

#Colony-stimulating factors CSF 1

#colorectal cancer 1

#comparability 1

#complement factor C3 inhibitor 1

#Complement Mab Drug Discovery 1

#complement system 5

#complement-dependent cytolysis 2

#Complement-Mediated Diseases 1

#Complete Freund's Adjuvant (CFA) 1

#compstatin 1

#conditional approval 1

#conformations 1

#Cosentyx 1

#Crohn's disease 3

#CrossMAb technology 1

#CT-P13 1

#CTLA, cytotoxic T lymphocyte antigen 1

#CTLA4 20

#cutaneous T-cell lymphomas (CTCLs) 1

#CV events 1

#Cytokine fusion proteins 1

#cytokine immune activators 1

#cytokine-release syndrome 1

#cytokines 7

#Cytolytic fusion proteins 1

#Cytomegalovirus (CMV) 1

#Cytotoxic T Cell Specific Immunotherapy 1

#cytotoxic T lymphocyte 2

#cytotoxic T lymphocytes 4 2

#cytotoxic T-lymphocyte antigen-4 4

#dabrafenib 1

#daclizumab 2

#Dendritic cell vaccine 4

#Dendritic cells 5

#dendrtic cell vaccine 1

#dengue vaccine 1

#Dengue virus 1

#DNA vaccine 1

#Domain antibody 1

#Dr. James P. Allison 1

#drug delivery 1

#Drug Prices 1

#DVD-IgTM 1

#Ebola 1

#Ebola mab 1

#Ebola monoclonal antibody 2

#ebola outbreak 1

#Ebola therapy 1

#Ebola virus mabs 1

#EBV infected lymphoma cells 1

#EBV-CTLs 1

#EC approval 1

#eculizumab 1

#EGFR 1

#Ektomun® 1

#EMA 2

#EMA approval 5

#EMA biosimilar guidelines 2

#Enbrel 1

#Epstein-Barr virus (EBV) 1

#Erbitux 1

#ESMO 2014 1

#etanercept 1

#Evolocumab 1

#Eylea (aflibercept) 1

#Fast track priority approval 1

#FDA biosimilar guidelines 2

#FDA analysis 1

#FDA approval 5

#FDA fast track 1

#FDA fast track review 1

#FDA priority review 1

#FDA review 1

#fibrosis 1

#first biosimilar mab 1

#fluorescence-activated cell sorting 1

#foreign immunodominant peptide (GP33) 1

#Formula Pharma 1

#Fully Human mabs 1

#G protein-coupled receptors (GPCRs) 1

#Garvin Institute 1

#GD22 1

#GEN 1

#genetically modified T cells 1

#Genticel 1

#Global cancer market 2014 1

#glycoprotein B specific mab 2

#Glycoprotein H mab 1

#GM-CSF 1

#GMP 1

#golimumab 1

#GPCR mabs 1

#GVAX 1

#H1N1 strain 1

#HBV mab 1

#health insurance 1

#healthcare 1

#heaptocellular carcinoma HCC 1

#Hematologic Malignancies 1

#hepatitis B 1

#hepatocyte growth factor 1

#Heptares StaR® proteins 1

#Heptares Therapeutics 1

#HER-Vax 1

#HER2 2

#HER2+ve breast cancer 1

#Herceptin 1

#Herceptin® factory 1

#Herpes Simplex Virus 1

#high affinity antibody fragments 1

#high-affinity, PEGylated Fab 1

#histamine 1

#histidine rich protein2 (HRP2) 1

#HIV mab 2

#Holoclar 1

#HPLC 1

#HuMab 5B1 1

#human epidermal growth factor receptor 1

#human T cell leukaemia virus type-I 1

#Humaneered® mab 1

#humanized monoclonal antibody 1

#Humira 2

#Ibalizumab 1

#Igenica Biotherapeutics 1

#IgG 1

#IgG2 1

#IgG4 mab 1

#IL-17A 1

#IL-1α /IL-1β 1

#IL12 1

#IL17 inhibitors 2

#IL2 1

#IL2 receptor 1

#IL23 1

#IL23 pathway 2

#IL23A mab 2

#IL6 2

#IL7/15 1

#immune cells 1

#immune monitoring 1

#Immune Pharma 1

#immune response 3

#immune system 1

#Immune System Activation ISA 1

#immuno activation 1

#immuno-oncology 47

#immunoconjugates 1

#immunodominant CTL epitope 1

#immunostimulation 1

#immunostimulator 1

#immunosuppression 1

#immunotherapy 64

#immunotoxins 3

#improved biologics 1

#IMS Health 1

#Imugene 1

#inflammation 1

#inflammatory bowel disease 1

#infliximab 5

#Influenza 1

#influenza vaccine 1

#Innate immunity 2

#Innate Immunotherapeutics 1

#Innate Pharma 1

#Inotuzumab ozogamicin 1

#interferons 2

#interleukin 1

#Interleukin 15 ( IL15) 1

#Interleukin 17A 1

#interleukin 23 1

#interleukin 6 2

#interleukins 1

#Intracellular Antibody Capture IAC 1

#ipilimumab 6

#J&J 1

#JAMA Oncology 1

#JCO 1

#Johns Hopkins 1

#Journal for Immunotherapy of Cancer 2

#Juno therapeutics 1

#juvenile idiopathic arthritis 1

#Kadcyla 1

#KaloBios 1

#KB001-A 1

#Keystone Symposia 1

#Keytruda 2

#Kite pharma 1

#Kyowa Hakko Kirin 1

#LAG-3 2

#LAG-3 (CD223) 2

#LAG3 1

#lampalizumab 1

#LC/MS 1

#LDL cholesterol 1

#lempalizumab 1

#leukemia 1

#licensing deal 1

#ligands 1

#Lindis Biotech 1

#lipid lowering 2

#listeria vaccine 1

#Lucentis 2

#lung cancer 4

#Lymphoma 1

#M-CSF 1

#mab 1

#mAb mixtures 1

#mab specificity 1

#mabs 4

#MabVax 1

#macrodrug 1

#MacroGenics 1

#macrophage 1

#macular degeneration 1

#malaria diagnosis 1

#manufacture 1

#marketing rights 1

#mast cells 1

#MaxCyte 1

#mCRPC 1

#Medimmune 1

#Meditope Biosciences 1

#Melanoma 6

#melanoma immunotherapy 1

#melanoma review 1

#melanoma therapy 1

#melanoma vaccine 1

#Meningococcol B Vaccine 1

#Merck 2

#metastatic breast cancer 1

#metastatic melanoma 5

#microsomal vesicles 1

#Mogamulizumab 1

#monoclonal antibodies 3

#Monoclonal antibodies (mAbs) 53

#monoclonal antibody 13

#monocytes 1

#Monomeric Fc 1

#MTD, maximum tolerated dose 1

#Multidrug resistance (MDR) 1

#multitargeting 1

#multivalent antibodies 1

#Mylotarg® 1

#NanomAbs 1

#Natalizumab 1

#Nature 1

#Nature Medicine 1

#NCE/NME 1

#NEJM 3

#New Drug Approvals 1

#NHance™ 1

#NHL 1

#NIAID 1

#NIH 1

#NIST 1

#Nivolumab 6

#NK cell immunotherapy 1

#NK cells 11

#NKG2D ligand 1

#NKTm cells 1

#NOAEL, no observed adverse effect level 1

#Non Hodgkin Lymphoma NHL 1

#Non-Hodgkin Lymphoma 2

#Novartis 3

#NSCLC 6

#Nurimmune 1

#obinutuzumab 1

#ofatumumab 1

#OmniFlip 1

#OmniMouse 1

#OmniRat 1

#Oncobiologics 1

#oncology 2

#Oncology drug development 1

#Oncolytic immunotherapy 5

#oncolytic vaccines 2

#oncolytic viruses 3

#oncovaccine 9

#OncoVax 1

#Ono Pharma 1

#Opdivo 2

#Open Monoclonal Technology OMT 1

#OPN-305 1

#Opsona Therapeutics 1

#Orphan Drug Designation 1

#Ossianix 1

#Ossianix VNAR Phage Display Libraries 1

#Osteoarthritis OA 1

#ovarian cancer 1

#overall response rate ORR 1

#Overall survival 2

#OX40 2

#OX40 agonist 1

#Pamlico Biopharma 1

#pancreatic cancer 1

#Pandemic influenza 1

#paroxysmal nocturnal hemoglobinuria PNH 1

#PASI 1

#PASI 75 1

#PCSK9 inhibitors 2

#PD-1/PD-L1 24

#PD-L1 (B7-H1) immunohistochemistry IHC 1

#PD/PK 1

#PD1 1

#PD1 inhibitor 7

#PD1/PDL1 antagonists 2

#PDL1 1

#PDL1 biomarker 2

#PDL1 inhibitor 2

#PDL2 2

#Pediatric cancer 1

#PEGylation 1

#pembrolizumab 5

#peptide 1

#Peregrine Pharma 2

#Pfizer 1

#Phagocytosis 1

#Pharmaceutical Industry 1

#pharmacodynamics 2

#pharmacokinetics 2

#Phase 1 1

#Phase I 1

#Phase I starting dose 1

#Phase II 1

#Phase III data 2

#Philogen 1

#Phosphatidylserine-Recognizing Peptide 1

#Pidilizumab 2

#PK 1

#PK/PD 1

#PLoS One 3

#PLOS Pathogens 1

#Pneumococcal pneumonia 1

#poly(N-isopropylacrylamide) (PNiPAAm) 1

#polyclonal recombinant antibodies 1

#polymer micelles 1

#Polytherics 1

#positron emission tomography PET 1

#POTELLIGENT® 1

#Progenics Pharma 1

#programed cell death 5

#programmed cell death ligand 1 (PD-L1) 3

#protein-protein interactions 1

#PS mab 1

#Pseudomonas aeruginosa 1

#PSMA ADC 1

#psoriasis 5

#Psoriatic arthritis PsA 1

#R&D 1

#R&D collaboration 1

#R&D deal 1

#R&D pipeline 1

#ranibizumab 3

#receptor tyrosine kinase 1

#reference medicinal product 1

#Regeneron 1

#Remicade 3

#Remsima® (infliximab) 1

#Reuters 1

#Reverse Translational Medicine™ (RTM™) 1

#review 1

#Rheumatoid arthritis 1

#rheumatoid arthritis (RA) 3

#Rituxan 2

#Rituximab 4

#RNA CAR 1

#RNA immunotherapy 1

#RNA Vaccines 1

#Roactemra 2

#Roche 4

#Sanofi 4

#seasonal influenza 1

#secukinumab 1

#serogroup B meningococcal vaccine 1

#severe limbal stem cell deficiency LSCD 1

#Shire 1

#Side effects 1

#SIMPLE Antibody™ Platform 1

#Singapore 1

#single domain 1

#single photon emission computed tomogra 1

#SITC 2015 1

#skin immunology 1

#small cell lung cancer SCLC 1

#SnAP technology platform 1

#Solvanix 1

#Sonepcizumab 1

#SPECT 1

#StAbilize™ Technology 1

#stable antibodies 1

#state of the art review 1

#STC Biologics 1

#STD10, severely toxic dose in 10% 1

#stem cell therapy 1

#stem cell transplant 1

#stem cells 1

#Super Statins 1

#Symohogen 1

#systemic inflammatory response syndrome 1

#T cell activation 8

#T cell bispecific antibody 1

#T cell blockers 2

#T cell immunotherapy 2

#T cell leukemia/lymphoma 1

#T cell metabolism 1

#T cell Receptor 9

#T cell receptor signaling 3

#T cell regulation 2

#T cell tolerance 1

#T cell vaccines 1

#T cells 5

#T cells regulatory/T reg 2

#T reg 3

#T-cell immunoglobulin mucin domain TIM 1

#TaiMed Biologics 1

#targeted therapy 1

#TCR 1

#TCR signaling 2

#TG 4010 1

#Th2 1

#The Society for Immunotherapy of Cancer 1

#Therapeutic Antibodies 3

#Therapeutic antibody 1

#therapeutic mabs 3

#therapy 1

#ThioBridge™ 1

#TIL 1

#tildrakizumab 2

#TILs 1

#TIM-3 2

#TLR 1

#TLR mab 1

#TLR8 1

#TNF 2

#TNF inhibitors 4

#TNF superfamily 4

#TNFRSF25 agonistic mab 1

#Tocilizumab 3

#toll like receptor 1

#Top 10 drugs 1

#top 10 mabs 2

#top 10 ranking table 1

#top selling human medicine 2

#toxicology studies 1

#Transgene 1

#trastuzumab 2

#tregalizumab 1

#tremelimumab 1

#TrendAbs 1

#TrispecificAbs 1

#True Human™ monoclonal antibodies 2

#True North Therapeutics 1

#Trumenba 1

#tumor antigens 4

#tumor immunology 4

#tumor infilterating lymphocytes TILs 2

#tumor infiltrating lymphocytes 4

#tumor microenvironment 3

#Tumor necrosis factor alfa 1

#tumor-associated carbohydrate antigen 1

#Tumor-infiltrating Lymphocytes 1

#Ulcerative colitis 2

#University South Florida 1

#Unum Therapeutics 1

#UPENN 1

#vaccine technology 1

#vaccines 3

#Vaccinogen 1

#vascular disease 1

#Vaxiclase 1

#vemurafenib 1

#VentiRx Pharma 1

#VNAR shark antibodies 1

#vvemurafenib 1

#Vγ9Vδ2 T cell 1

#Webinar 1

#WuXi PharmTech. 1

#XBiotech 2

#Xilonix™ 1

#YaleCancer 1

229E 1

AAV-based 1

adc 72

adjuvant 1

adoptive T-cell 1

adverse 1

antibodies 1

antibody 1

Antibody response 1

anticorps 1

article scientifique 3

autoimmmune 1

autoimmune disease 1

autoimmunity 1

awareness 1

Belgium 1

biologics 1

biopharma 1

biotech 2

bovine 1

broken link 3

cancer 8

CAR T cell 2

CAR-T 1

cardiology 1

cartoons 1

casirivimab 1

CD4 3

células dendríticas 1

Cindy 1

Clinical trial 2

clinical trials 1

Cocvid-19 1

complement 1

coronavirus 2

correlate 1

correlate of protection 1

Council of Europe 1

covid-19 50

Cows 1

curation 1

Current opinion in Immunology 1

Cypress 1

cytokines 1

DCs 1

dendritic cells 1

dengue 1

development 1

diabetes 1

Drug Costs 1

EMA 1

European 1

evolution 1

FDA 1

gene editing 2

gene therapy 1

genome editing 2

Global 1

Global health 1

GPCR 1

graphics 1

graves' 1

HCoV 1

healthcare social media 1

hematology 11

herpes 1

herpes labialis 1

HSV-1 1

IDSA 1

imdevimab 1

immune response 1

immunité sociale 1

immunology 2

Immunotherapy 4

immunotoxins 1

impact 1

Infections 1

influenza 1

interactive 1

JAK 1

Janssen 1

Journal 1

lens.org 1

llama antibodies 1

LNP 1

Low IL-2 in lupus therapy 1

lung cancer 1

lymphome 1

Malaria 1

medical 2

medicine 1

meganuclease 1

melanoma 2

mRNA 1

mRNA therapy 1

MSC 1

mucosal 1

nanobody 1

nanopaticle 1

nanovaccines 1

natural killer 1

neutralization 1

oncology 1

organ donation day 1

organ donors 1

outcomes 1

ovarian cancer 1

patents 1

phage 1

phage therapy 1

phase I 1

Protein-protein-interactions 1

psoriasis 1

real-time 1

Recovery trial 1

Regeneron 1

Registry 1

REpurposing 1

research 2

research articles 1

review article 2

rotavirus 1

RSV 1

SAb Therapeutics 1

SARS-CoV-2 3

side effects 1

side effetcs 1

smoking 1

solid tumor 1

stem cells 1

T cells 2

therapeutic antibody 1

Therapy 1

topical 1

traitement 1

transplant recipients 1

Type I diabetes mellitus (T1DM) 1

vaccin 2

vaccination 2

vaccine 10

Vaccine efficacy 1

Vaccines 3

vaccinology 16

VHH 1

video 1

videos 1

virus 1

visual 1

vitellogenin 1

VP6 1

YouTube 1

Immunology and Biotherapies

Page Ressources et Actualités du DIU immunologie et biothérapies

Curated by Gilbert C FAURE

Your new post is loading...

Scooped by Gilbert C FAURE

Scoop.it!

Alethia Biotherapeutics Obtains a Notice of Allowance for a Patent for the Use ... - MarketWatch (press release) | Immunology and Biotherapies | Scoop.it

From www.marketwatch.com - July 27, 2012 6:15 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.medpagetoday.com - July 27, 2012 6:10 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.smartbrief.com (via @RIBloodCenter) - July 27, 2012 4:56 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.gtcbio.com - July 26, 2012 3:23 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From news.google.com - July 26, 2012 2:51 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.symposier.com - July 26, 2012 11:33 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From relationship.pr-8.com - July 25, 2012 3:13 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.onclive.com - July 25, 2012 1:52 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.ncbi.nlm.nih.gov - July 25, 2012 11:13 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.mdlinx.com - July 25, 2012 9:00 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.ncbi.nlm.nih.gov - July 25, 2012 4:55 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.health.harvard.edu - July 25, 2012 3:49 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.stemcell.tv - July 25, 2012 3:48 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From news.google.com - July 27, 2012 6:14 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

Community-wide consensus process generates a framework for reporting of T-cell experiments in clinical immunology | TRON Translational Oncology Mainz | Immunology and Biotherapies | Scoop.it

From tron-mainz.de (via @TRON_MZ) - July 27, 2012 4:57 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From chirurgie.edimark.fr - July 26, 2012 4:01 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From in.reuters.com - July 26, 2012 2:52 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From news.google.com - July 26, 2012 2:51 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions | Immunology and Biotherapies | Scoop.it

From www.prnewswire.com - July 26, 2012 11:30 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.biosimilarnews.com (via @NovationNews) - July 25, 2012 1:54 PM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy | Antibody Chain | Immunology and Biotherapies | Scoop.it

From www.antibodychain.com - July 25, 2012 11:14 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.sciencedaily.com - July 25, 2012 9:05 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From www.symposier.com (via @SympoPharmaco) - July 25, 2012 8:59 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From blog.invest.vic.gov.au - July 25, 2012 4:54 AM

No comment yet.

Scooped by Gilbert C FAURE

Scoop.it!

From medicalxpress.com - July 25, 2012 3:49 AM

No comment yet.

Immunology and Biotherapies

Alethia Biotherapeutics Obtains a Notice of Allowance for a Patent for the Use ... - MarketWatch (press release)

Medical News: Drug Cut Skin Cancers After Transplant - in Transplantation, Kidney Transplantation from MedPage Today

Mesoblast plans trial of stem cell therapy for rheumatoid arthritis

9th Stem Cell Research & Therapeutics Conference

Precision StemCell's Revolutionary InVivo Adult Stem Cell Reprogramming ... - MarketWatch (press release)

Symposier - CD47 Antibody treatment shrinks or eliminates human cancer tumors in mice

The Advantages of Placenta Banking - Relationship Articles Daily

Antibody-Drug Conjugates: Guided Missiles Deployed Against Cancerous Cells

Serum IgG responses against Asp... [Biol Blood Marrow Transplant. 2012] - PubMed - NCBI

Oncology News - Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis |4144529

Effect of a monoclonal antibody to PCSK9, REGN727/SAR... [Lancet. 2012] - PubMed - NCBI

New guidelines urge immediate treatment after HIV infection - Harvard Health Publications

Pluristem Focuses On Therapeutic Cells Delivered Intramuscularly ...

Intellect Neurosciences to Present at Antibody Summit in San Francisco - MarketWatch (press release)

Community-wide consensus process generates a framework for reporting of T-cell experiments in clinical immunology | TRON Translational Oncology Mainz

Edimark Santé : Publications - Le Courrier de la Transplantation

Pluristem, NIH to study stem cells to treat radiation syndrome - Reuters

ACT Issued Broad Patent for Human RPE Cells Derived From All Types of ... - MarketWatch (press release)

Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions

World’s first biosimilar antibody* is approved in Korea

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy | Antibody Chain

Sweat glands grown from newly identified stem cells

Symposier - Nimotuzumab: Proposed Mechanism of Action

World’s leading transplantation experts lock in Melbourne for 2015 | Invest Victoria Blog

Researchers discover new target for vaccine development in abundant immune ... - Medical Xpress